Beta Bionics, Inc. (BBNX) NASDAQ

14.67

-0.2377(-1.59%)

Updated at May 09 10:16AM

Currency In USD

Valuation

Market Cap150.41M
Enterprise Value127.23M
P/E Ratio-23.21
PEG Ratio3.53
Price/Sales Ratio17.4
Price/Book Ratio8.5
Enterprise/Revenue16.78
Enterprise/EBITDA-26.55

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-0.75
Operating Margin-0.65

Management Effectiveness

Return On Assets-0.19
Return On Equity-0.51

Income Statement

Revenue65.12M
Revenue/Share0.86
Gross Profit35.89M
EBITDA-44.1M
Net Income-54.76M
Diluted EPS-8.6

Balance Sheet

Total Cash103.58M
Total Cash/Share2.39
Total Debt7.26M
Total Debt/Equity0.1
Current Ratio6.29
Book Value Per Share1.75

Price History

52-Week Change-36.9
52-Week High24.5
52-Week Low8.89
Moving Average 50 Days13.42
Moving Average 200 Days15.73

Statistics

Average Volume474,681
Shares Outstanding43.36M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A